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Abstract
The nucleocapsid protein (N) and the phosphoprotein (P) of nonsegmented negative-strand (NNS) RNA viruses interact with
each other to accomplish two crucial events necessary for the viral replication cycle. First, the P protein binds to the
aggregation prone nascent N molecules maintaining them in a soluble monomeric (N
0) form (N
0-P complex). It is this form
that is competent for specific encapsidation of the viral genome. Second, the P protein binds to oligomeric N in the
nucleoprotein complex (N-RNA-P complex), and thereby facilitates the recruitment of the viral polymerase (L) onto its
template. All previous attempts to study these complexes relied on co-expression of the two proteins in diverse systems. In
this study, we have characterised these different modes of N-P interaction in detail and for the first time have been able to
reconstitute these complexes individually in vitro in the chandipura virus (CHPV), a human pathogenic NNS RNA virus. Using
a battery of truncated mutants of the N protein, we have been able to identify two mutually exclusive domains of N
involved in differential interaction with the P protein. An unique N-terminal binding site, comprising of amino acids (aa) 1–
180 form the N
0-P interacting region, whereas, C-terminal residues spanning aa 320–390 is instrumental in N-RNA-P
interactions. Significantly, the ex-vivo data also supports these observations. Based on these results, we suggest that the P
protein acts as N-specific chaperone and thereby partially masking the N-N self-association region, which leads to the
specific recognition of viral genome RNA by N
0.
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Introduction
Chandipura virus (CHPV) is a prototype member of the family
Rhabdoviridae in the order Mononegavirales, which also includes
vesicular stomatitis virus (VSV) and rabies virus (RAV). This virus
belongs to the broader group of negative-strand RNA viruses
(NSRVs), which includes many pathogenically significant viruses,
like avian influenza, measles, and Ebola. CHPV has repetitively
caused severe outbreaks of encephalitis in parts of India [1–6] and
has recently been classified as an emerging human pathogen in the
Indian subcontinent [4,7]. Like other members of the Rhabdovi-
rus family, its single-stranded, negative-sense RNA genome is
encapsidated with the nucleocapsid protein (N) into a helical
nucleocapsid (NC) structure which together with the viral RNA
dependent RNA polymerase (RdRp) components, the large
protein (L) and the phosphoprotein (P), is packaged into the
virion particle. This genome RNA enwrapped within the
nucleocapsid in association with the viral RdRp forms the
Ribonucleoprotein particle (RNP), a self-sufficient entity for
infection [8].
Encapsidation of the genome RNA by N protein is not only
essential for protecting the viral genome from RNase action, but, is
also believed to play a major role in the switching of the viral
transcription to replication mode [9]. A unique characteristic
feature of all nonsegmented negative-strand RNA viruses
(NNSRVs) is that the active template for RNA polymerization
reactions is the encapsidated genome RNA, and never the naked
RNA. Also, during replication, the nascent RNA is encapsidated
concomitantly to its synthesis so that it can sustain subsequent
rounds of replication, or be packaged within the virion particle.
This is supported by the observation that continuous synthesis of N
protein and its stoichiometric availability is indispensible during
viral replication [10–13]. One fundamental requirement for the N
protein is that it must specifically encapsidate the viral genomic
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rhabdoviral N protein alone is incapable of performing this task.
According to numerous studies, N protein when expressed alone
forms large insoluble aggregates [14–16] and binds to short
cellular RNAs non-specifically [17–21]. Conversely, when co-
expressed with the P protein, a major fraction of the N protein is
rendered soluble and free of non-specific RNA. P was reported to
form complex with monomer N (N
0-P) [22–25] thereby inhibiting
N-N self association [16,26–28] and also imparting specificity
towards viral RNA sequence [26,28,29]. Therefore, interaction
with the P protein is an imperative requirement for the
maintenance of encapsidation competent N protein. On the other
hand, P protein also interacts with the mature nucleocapsid in
order to recruit the L polymerase onto its template, as the L
protein cannot bind to the N-RNA template by itself [30,31]. This
interaction has been studied in considerable details by analysing
the crystal structure of VSV nucleocapsid like particles (NLP) in
association with the C-terminal domain of P (PCTD). It showed
that decameric structures of N enwrapping a 90 nt RNA which
remains associated with 5 molecules of P protein (N:P molar ratio
of 2:1) [18,32]. The C-terminal domains of both N and P proteins
were found to participate in such N-RNA-P complex formation
[18,32].
However, for the monomer N-P complex (N
0-P), the interacting
domains of N, and the nature of the interaction at large, remains
uncharacterised. One of the major obstacles for such biochemical
and structural studies has been the unavailability of soluble N
0
protein. However, recently Leyrat et al. has reported the structure
of a N-terminal 21 aa deleted version of the VSV N protein with
the first 60 aa of VSV P (ND21
0-P60) [33]. More significant progress
has been made in regard to the N
0 interacting domains of the P
protein. Chen et. al. has shown that for VSV, N-terminal 11–30
amino acids of P protein are essential in keeping N in soluble form
(N
0-P complex formation) [14]. This N
0-binding region of VSV P
was shown to be globally disordered and encompasses the
transient a-helices [34]. Similar observations have been made
for Rabies, Sendai and HPIV3 viruses, where N-terminal 40 aa of
P protein has been implicated for N
0-P interactions [35–37].
These studies pointed towards the fact that P protein has
independent domains for interaction with monomer and oligo-
meric N protein. The presence of two separate N binding regions
in P, strongly suggests that the N protein might also utilize two
separate P binding domains in its different oligomeric states, i.e.
N
0 and N-RNA.
In this study, we chose to characterise the P binding region(s) of
CHPV N. Recently, we have delineated the self-association and
RNA binding domains of CHPV N [21]. It was found that the N-
terminal 47 aa together with residues 180–264 were important for
proper nucleocapsid like structure formation, while the C-terminal
domain was found dispensable for the same. Interestingly, it was
also found that the RNA recognition event was a function of the
oligomerization status of the protein. In brief, the C-terminal 102
aa (residues 320–422) was found to be important for the specific
recognition of the leader RNA sequence of CHPV, and this
function is active only under monomeric conditions of the protein.
Upon oligomerization, the RNA recognition specificity is lost and
the N-terminal domain was found to mediate the non-specific and
progressive enwrapping of the genome RNA. In this current work,
we have characterized the different modes of CHPV N-P
interactions in ex-vivo and in in vitro systems using deletion
mutagenesis. Our results indicate the presence of two mutually
exclusive P interacting domains in CHPV N. Consistent to
previous observations in related viruses, a C-terminal P binding
region has been observed that is functional only under oligomeric
condition. In addition, a previously unknown N-terminal region of
N has been identified that binds to P only in its monomeric form
(N
0-P). This helps sheds light upon the intricate molecular
machinery that controls encapsidation in CHPV and other
rhabdoviruses at large. We have also suggested a model that
helps to explain the molecular basis of the N specific chaperone
like activity of P protein, and subsequent specific encapsidation of
the viral RNA by N.
Results
Study of the interaction between CHPV N and P proteins
in Vero-76 cells
To monitor the interaction of CHPV N and P proteins in living
cells, in isolation of other viral proteins, the two proteins were
either expressed individually or co-expressed in different molar
ratios in Vero-76 cell line. Immunofluorescence against untagged
N (pCDNA3.1(+) N) and P protein (pCDNA3.1(+) P) reveals that,
when expressed alone, N protein exhibits a punctate distribution,
while P protein demonstrated a homogeneous distribution,
throughout the cytoplasm (Figure 1A and B). Transfection of an
N-terminal EGFP tagged N construct resulted in a similar
punctate distribution. EGFP alone has a characteristic homoge-
nous distribution throughout the cell (Figure 1C and D); thus
implicating that EGFP fusion does not have any effect upon the
intracellular distribution of the protein and it is N, that is
responsible for conferring such a punctate distribution of the
fusion protein. Similar distribution of EGFP tagged CHPV N
protein has also been reported earlier [16] and could be attributed
to the self-association character of the protein [21,29].
Co-transfection of the plasmids encoding EGFP-N and
untagged P proteins in a 1:1 ratio resulted in redistribution of
the punctate structures of N into a complete homogenous
distribution (Figure 1E). Among cells exhibiting GFP fluorescence,
about 90% showed such change in the distribution pattern of N.
Immunofluorescence against P (red), confirmed co-expression of N
and P proteins in these cells and its co-localization with N
(Figure 1F and G). The remaining 10% cells, was found to be
lacking in the expression of P, and therefore showed characteristic
punctate structures of N (Figure S1). It is thus evident that the P
protein can impart chaperone-like activity in the intercellular
milieu for the solubilisation of the otherwise punctate N protein.
On the contrary, co-transfection of plasmids encoding EGFP-N
and P proteins in 1:0.5 ratio resulted in an entirely different
observation. In this case, P failed to homogenize the punctate
distribution of N, and interestingly, the P specific fluorescence (red)
was found to completely co-localized with the aggregated
structures of N (Figure 1H to J). It appears that, when co-
expressed in 1:0.5 ratio, the stoichiometric availability of P is
insufficient for it to exert its chaperone like activity upon N.
However, co-localization of P with the punctate structures of N
under this condition confirms the ability of P to interact with
aggregated N.
To further validate this data, cells expressing either EGFP-N
alone or EGFP-N and P together in different ratios were lysed and
centrifuged at 13,000 rpm. Supernatant and pellet fractions were
analyzed for N and P using specific antibodies (Figure 2A). As
expected, co-expression in 1:1 ratio resulted in solubilisation of a
major fraction of the otherwise insoluble N, re-establishing the
chaperone like activity of P [16,27]. However, when co-transfected
in 1:0.5 ratio, N was majorly found in the pellet fraction. This
confirms that at 1:0.5 ratio P fails to exert its chaperone like
activity upon N. In addition, P protein, which is generally soluble,
was found almost entirely in the pellet fraction when co-
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interaction with aggregated insoluble N. The supernatant fraction
obtained from the co-expression of N-P in 1:1 ratio, were analyzed
by centrifugation through a 10–60% sucrose density gradient to
determine the oligomerization status of N in this soluble
preparation. Fractions were collected from the bottom of the
gradient and blotted against N and P (Figure 2B). Interestingly,
there are two major populations of N widely separated from one
another. A significant population was found to penetrate up to the
7
th fraction; showing considerably higher sedimentation value than
decameric N (10
th fraction, as shown previously in [21]).
Immunoblotting with P antibody confirmed the association of P
with this population of N. This accounts for its higher
sedimentation value than decameric N (Figure 2B, lower panel).
The second major population of N, although remained associated
with P, was found to have a much lower sedimentation velocity
(penetrated up to the 17
th fraction only). It seems that this
population represents a low molecular weight complex, consisting
Figure 1. CHPV N and P proteins interact differentially in transfected cells depending on their stoichiometric availabilities. (A) Vero-
76 cells were transfected with 2 mg pCDNA 3.1 (+) N and immunofluorescence performed with N-Ab, 24 hours post transfection. N exhibits a
punctate distribution in the cytoplasm. (B) Immunofluorescence of Vero-76 cells transfected with pCDNA 3.1 (+) P, with P-Ab. P exhibits a smooth
distribution in the cytoplasm. (C) GFP fluorescence of Vero-76 cells transfected with pEGFP-C1 N. GFP-tagged N maintains its punctuated distribution.
(D) GFP fluorescence of Vero-76 cells transfected with pEGFP-C1 vector alone. GFP alone shows characteristic smooth fluorescence throughout the
cell. (E to G) Vero-76 cells co-transfected with pEGFP-C1 N and pCDNA 3.1 (+) P in a 1:1 ratio. P was detected by immunofluorescence (F).
Colocalization of GFP-N with P is shown in the merged image (G). Co-expression with P redistributes the otherwise punctuated N into a more
homogenous fluorescence. (H to J) Co-transfection in a 1:0.5 ratio. The lower abundance of P is insufficient to homogenise the punctuated
distribution of N (H). Immunofluorescence against P reveals colocalization of P with oligomeric forms of N (I and J). All data were captured on a laser
scanning confocal microscope (Carl Zeiss). All Immunofluorescence were performed with anti-rabbit TRITC conjugated secondary antibody. 2 mgo f
DNA was used for all transfection, except for H, I and J where 1 mg of pCDNA 3.1 (+) P was used. The bar represents 5 mm.
doi:10.1371/journal.pone.0034623.g001
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0-P proteins, as depicted by sedimentation
values. Although, it is difficult to determine the exact stoichiometry
of N to P, this experiment clearly shows the formation of two
distinct complexes among N and P when co-expressed. In
addition, presence of RNA in the two complexes was tested by
measuring their A280 nm/A260 nm ratio. Higher RNA content
should be reflected by a lower A280 nm/A260 nm ratio compared to
fractions with lesser or no RNA content. The larger complex (7
th
fraction) corresponding to decameric N-P populations, exhibited a
much lower A280 nm/A260 nm ratio compared to the 17
th fraction,
which corresponds to N
0-P complexes (data not shown). This
confirms that the larger complex is an N-RNA-P complex, where
decameric N have encapsidated cellular RNAs non-specifically.
The smaller N
0-P complex seems to be devoid of any cellular
RNA.
N forms distinct complexes with P in vitro
Next, a cell free assay system was employed to further
characterize the different N-P interactions and the detail
stoichiometry involved in it. To this end, we have performed
size-exclusion chromatography through Superdex-200 column
using bacterially expressed, purified N and P proteins [27,38]. In
tune with previous reports [21,29], N protein showed character-
istic oligomerization pattern in size-exclusion chromatography,
eluting at around 9.5 ml, between ferritin and catalase (Figure 3A).
We have previously reported that this population of N represents
ring shaped nucleocapsid like particle under transmission electron
microscopy [21]. P eluted at 13.25 ml (Figure 3B), suggesting that
a major fraction of the protein remains in dimer form, thereby
validating the concentration dependent dimerization property of
this protein [39]. Interestingly, prior incubation of N and P
together at 4uC for 30 minutes resulted in formation of a high
Figure 2. Soluble-insoluble fractionation and sucrose density gradient centrifugation. Stoichiometry of N and P ratio is important for the
N specific chaperone activity of P. (A) Total (Tot), Soluble (Sol) and Insoluble (Pel) fractionation of Vero-76 cells transfected with different ratios of
pEGFP-C1 N and pCDNA 3.1 (+) P at 24 hours post-transfection. N and P proteins were detected by immunoblotting with N and P Ab respectively. It is
evident that a 1:0.5 N-P ratio is incapable of solubilising the otherwise insoluble N; however, a 1:1 ratio can do so. GAPDH was used as a loading
control. (B) Oligomerization status of soluble N. Sucrose density gradient centrifugation of the soluble fraction of cells transfected with 1:1 ratio of
GFP-N and P constructs. Fractions were collected from the bottom of the tube, and alternative fractions were immunobloted with N and P Abs. The
curve shows the band intensities representing distribution of GFP-N and P against the fraction number. While majority of the soluble fraction of N is
found in the monomeric form (fraction 17), a substantial amount is also found in fraction 7, indicating decameric forms. P is found to interact with
both the populations of N. However, other stoichiometries of homo-oligomerization cannot be ruled out (fractions 13 through 17).
doi:10.1371/journal.pone.0034623.g002
Interaction of CHPV N and P Proteins
PLoS ONE | www.plosone.org 4 April 2012 | Volume 7 | Issue 4 | e34623molecular weight complex which eluted at 8.5 ml (Figure 3C). The
exact molecular weight of the complex was difficult to determine
as the elution volume is close to the void volume of the column.
The molar ratio of N to P in this species was determined by
densitometric analysis to be 2:1. Therefore, it can be inferred that
the P protein interacts with the ring shaped nucleocapsid like
particles to form this high molecular weight complex.
Treatment of CHPV N with Sodium Deoxycholate (DOC)
results in the dissociation of the N oligomers into monomers [29].
This phenomenon has been used to confirm the P interacting
ability of monomer N as previously indicated by the density
gradient results (Figure 2B). Bacterially expressed, purified N was
treated with 1% DOC for 30 minutes at 4uC and subsequently
DOC was removed by dialysis either in the absence or presence of
P protein. The resulting complex was subjected to gel-filtration
chromatography (Figure 3D and E respectively). In absence of P,
removal of DOC resulted in the restoration of oligomeric status of
N protein as evident from the identical gel-filtration profile
encountered without DOC treatment (compare Figure 3A and D).
However, presence of P during DOC removal resulted in a
substantial change in the gel-filtration profile of N (compare 3A
with E and Figure 3F). The result shows that, a significant fraction
of N interacts with the P protein to form a series of low molecular
weight complexes at the expense of the high molecular weight
complex mentioned above (compare Figure 3E and C). Majority
of these complexes eluted between 12–13 ml (Figure 3F) in a range
between 100-80 kDa. Interaction of a single subunit of N with
either monomer or dimer P could account for such low molecular
weight complexes. This possibility was also supported by the
densitometric analysis of respective bands. While for the 12
th ml
fraction (Figure 3E), the estimated N to P ratio was 1:2, for the
12.5–13 ml fractions it was 1:1. Clearly, P exerts chaperone like
activity upon N, thereby inhibiting its self-association and thus
resulting in its slower elution in size-exclusion chromatography.
Till date, such N-P complexes have been encountered only upon
co-expression of both the proteins together [14,18]. Here it has
been possible to reconstitute and partially characterize the two
different types of N-P complexes (Oligomer N-P, Monomer N-P)
separately under in vitro conditions. Moreover, this data further
substantiates the differential interactions of N and P proteins when
expressed in live cells.
N protein utilizes its N and C terminal domains
independently for interaction with P in its monomer and
oligomer form respectively
Next, to establish the domain(s) of the N protein involved in its
interaction with P, we have employed a set of deletion mutants of
N previously described in reference [21]. Figure 4 shows a
schematic representation of these deletion mutants along with the
functional domains involved in self-association and RNA binding
[21]. However, for this study we have included two additional
deletion mutants, N(22–422) and N(1–390). According to the
Figure 3. N forms distinct complexes with P in vitro. Size exclusion chromatography of bacterially expressed purified N and P proteins,
visualised by Coomasie brilliant blue staining. (A) N alone shows higher oligomeric distribution, suggesting decameric species. (B) P alone shows
characteristic dimeric forms. (C) N and P incubated together at 4uC for 30 minutes. Interaction between N (oligomer) and P is evident, as they co-elute
just after the void volume fraction. (D) N treated with 1% DOC for 30 minutes and subsequently dialysed to remove DOC. Though DOC treatment
dissociated the oligomeric N into monomeric forms, removal of DOC by dialysis allows them to re-oligomerize. (E) Similar to D, except for the fact that
DOC was removed in the presence of equimolar concentration of P protein. Presence of P protein during DOC removal retains the monomeric
population of N, and subsequently, monomer N-P complexes elute at around 12 ml. Elution profiles of gel filtration standard are shown for molecular
weight estimation. (F) Plot representing densitometric scans of N bands with respect to elution volume in ml.
doi:10.1371/journal.pone.0034623.g003
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an extended arm which interacts with the C-lobe of the preceding
N molecule [32,40]. However, upon deletion of these amino acids,
the truncated N still conserves its ability of self-association (albeit
with lower stability) and its association with P, as described
previously [40]. We therefore included N(22–422) in our studies to
check if this phenomenon is also true for CHPV N. Also, the
crystal structure of VSV N-RNA-P complex suggests that first 390
amino acids retains the C-terminal P interacting site of N, and is
therefore sufficient for its interaction with P [32]. However,
according to Takacs et al., the extreme C-terminal end of VSV N
plays a crucial role in VSV N-P interaction [41]. We have
therefore included N(1–390) in the following studies to evaluate
the importance of the C-terminal 32 aa in CHPV N-P interaction.
All these mutants were expressed in BL21(DE3) or in BL21(DE3)-
pLys S and purified by anion exchange chromatography (MonoQ
5/50 GL) as described under materials and methods and in [21].
An N-terminal six histidine tagged variety of the P protein (His-P)
was used for studying N-P interaction in vitro. The purified
truncated proteins were subjected to size-exclusion chromatogra-
phy through S-200 column to ensure their oligomerization status
as was reported previously [21]. The two new mutants N(1–390)
and N(22–422) were found to retain their propensity to form
oligomeric structures like wild-type N (Table 1).
Next, His-tag co-elution assay was employed to determine the
interacting ability of these truncated N proteins with the full length
His-P. To this end, His-P was incubated either with wild-type or
different truncated N proteins and the resulting mixture was then
subjected to binding with Ni-NTA resin and subsequently eluted
as described in material methods (Figure 5A). Co-elution of wild-
type N with His-P confirms its ability to interact with P in its
oligomeric form. It should be remembered that this interaction
represents binding of P with nucleocapsid like structures of N [21].
To authenticate the specificity of this interaction, BSA was
included which failed to co-elute with P. Deletion from the C-
terminal end of CHPV N was found to weaken this interaction
significantly, as a considerable amount of N(1–390) was observed
in the flow-through. However, a significant fraction also co-eluted
with P (Figure 5A). Further deletion from the C-terminal end
completely abrogated the P interaction ability and N(1–320), N(1–
220), N(1–47) failed to co-elute with P completely. Together, these
data indicate the presence of a P interacting domain at the C-
terminal end of CHPV N, residing within 320–390 amino acids.
However, further stabilization through residues 390–422 cannot
be ruled out from this observation. Interestingly, the N-terminal
deletion mutant N(180–422) or the middle deletant N(1/180–265/
422); although retains their C-terminal domain intact, failed to
interact with P. In this context it should be noted that these
mutants are oligomerization defective and exists in monomer and
Figure 4. Schematic representation of the wild-type N protein and the mutant N proteins used in this study. Prokaryotic clones were
made in pET3a vector for bacterial expression. Eukaryotic clones were made in pEGFP-C1 vector as N terminally GFP fused proteins. Different
functionally relevant domains are also shown [21]. The numbers represents amino acid positions.
doi:10.1371/journal.pone.0034623.g004
Table 1. Comparison of oligomerization status and cellular
distribution of different truncated mutants of CHPV N.
Truncated Proteins Oligomerization status Cellular Distribution
N(22–422) Octamer Punctate
N(48–422) Monomer Homogeneous
N(180–422) Monomer Homogeneous
N(1–47) Trimer Homogeneous
N(1–220) Tetramer Punctate
N(1–320) Octamer Punctate
N(1–390) Octamer Punctate
N(1/180–265/422) Trimer Punctate
Oligomerization status was estimated by size-exclusion chromatography
described previously (21), and cellular distribution was assessed by expressing
GFP fused constructs in Vero-76 cells, followed by confocal fluorescence
microscope.
doi:10.1371/journal.pone.0034623.t001
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CHPV, the C-terminal P interacting domain of N is highly
dependent upon the oligomerization status of the protein, and can
only be active in the characteristic nucleocapsid like structure of N.
This claim is substantiated by the fact that the N-terminal deletant,
N(22–422), which can form oligomeric structures like wild-type N
(Table 1) and also retains its C-terminal domain intact, can
interact with P. This observation is in agreement with the crystal
structure of VSV N-PCTD complex which demonstrated the
presence of such C-terminal P binding domain active only in the
ring shaped decameric structures of the protein [32]. Strikingly,
the co-elution ability of the mutant N(48–422), which exists
exclusively in the monomer form, points towards the existence of
another P interacting domain active in the monomeric form of the
protein. Further, inability of the monomer N(180–422) to interact
with P, indicates that this P interacting domain is probably located
at the N-terminal end of the protein.
To verify this possibility, we have slightly modified our His-tag
co-elution experiment. As described in Figure 3, P can interact
with 1% DOC treated monomeric N and form N
0-P complex after
removal of DOC. This phenomenon was used to verify the ability
of the C-terminal deletion mutants N(1–320), N(1–220) and the
middle deletant N(1/180–265/422) to interact with His-P protein
in their monomeric form. It is noteworthy that, although these
mutants retain the proposed N-terminal P binding domain, they
failed to interact with P protein in their native self-associated form
(Figure 5A). Hence, these mutants were treated with 1% DOC to
dissociated there self-associated structures and then subsequently
dialysed in presence of His-P protein. With the dialysed mixture
co-elution assay was carried out as described above. Interestingly,
prior incubation with DOC resulted in co-elution of all the three
mutants with His-P protein (Figure 5B). These data together
confirms that the N protein has an additional P interacting
domain(s) which is only accessible in the monomer form of the
protein. The ability of N(1/180–265/422) to interact with P
narrows down this interacting region within the N-terminal 180
amino acids of N. However, it is worthwhile to note that mutant
N(1–220) has a much weaker co-elution ability than N(1–320) or
N(1/180–265/422). This suggests that the residues 265–320 of N
(which are present in N(1/180–265/422) and N(1–320), but not in
N(1–220)) may also have a role in binding P under monomeric
conditions. In an attempt to further characterise the interacting
region, we also checked the P interaction ability of DOC treated
N(1–47). Failure of this mutant to interact with P suggests that the
first 47 amino acids of CHPV N may not play an important role in
N
0-P interaction. However, it must be considered that due to its
small size this mutant may not fold correctly into its functionally
relevant form.
Deletion of N-terminal 180 amino acids of N is sufficient
to abrogate N-P interaction in cells
Following the lead from our in vitro his-tag co-elution assays
which indicated the presence of two independent P interacting
domains in N, we decided to further validate the result by co-
immunoprecipitation experiment in transfected cells. The different
truncated mutants of N were checked for their P interacting ability
in the cellular milieu. All of the above mentioned mutants were
cloned into eukaryotic expression vector pEGFPC1 with a GFP
tag at its N terminal end (Figure 4). Mutants were expressed in
Vero-76 cell line and expression was confirmed by immunoblot-
ting with N-Ab. Electrophoretic pattern of all the mutants were in
agreement with their expected molecular weight. It must be
mentioned that, intracellular distribution pattern of these truncat-
ed N proteins, as monitored through confocal microscopy
(Figure 6A), could be correlated with their oligomerization status
as tabulated in Table 1. All three deletion mutants N(1–390), N(1–
320), N(22–422), confirms their oligomerization propensity by
formation of cytoplasmic punctate structures. The mutants
existing as monomers, i.e. N(48–422) and N(180–422) demon-
strated homogeneous distribution throughout the cytoplasm.
Figure 5. N protein utilizes two separate domains for interacting with P in its monomeric and oligomeric forms. N-terminally His-
tagged P protein (His-P) was allowed to interact with either wild-type N or different N mutants in 100 mM NaCl TET buffer containing 10 mM
Imidazole for 30 minutes at 4uC. Reaction mixtures were applied to Ni-NTA column and elution profile assayed by silver staining. L- loading; F- flow
through; W- 10 mM Imidazole wash; E- 250 mM Imidazole elution. (A) In the absence of 1% DOC treatment. Bovine Serum Albumin (BSA) was used as
negative control. (B) Wild-type N or N mutants were pre-incubated with 1% DOC for 30 minutes, followed by dialysis in presence of His-P, before
applying to Ni-NTA column. Samples were resolved in 12% SDS-PAGE and visualised by Coomasie brilliant blue staining.
doi:10.1371/journal.pone.0034623.g005
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tendency, N(1/180–265/422) or N(1–220) (Table 1), also showed
formation of punctate structures along with a homogeneous
distribution in the background. Probably, such distribution
represents a mixed population containing soluble and aggregated
forms of these mutants in the cellular milieu. In vitro, N(1–47) forms
trimers along with higher oligomers ([21] and Table 1). However,
it exhibited a homogeneous distribution pattern when expressed as
a GFP fused protein. Probably, GFP has diverse effect upon the
self-association ability of this short peptide and is responsible for its
soluble homogeneous distribution. Taken together, it is evident
that the punctate distribution of wild-type or truncated N proteins
in transfected cells is a manifestation of their self-association
tendency.
Next, we tested the P interacting ability of the GFP-tagged wild-
type N and truncated N mutants when co-expressed in Vero-76
cells. 24 hrs post transfection, proteins were metabolically labelled
with L-Methionine-S
35 and co-expression confirmed by immuno-
blotting with N Ab and P Ab (Figure 6B upper and lower panel).
Interaction was monitored by the ability to co-precipitate with the
P protein using P Ab (Figure 6C). GFP-N was used as a positive
control. In this context, it should be noted that during co-
expression, both monomer and oligomer forms of N are available
for interaction with P protein. All but one of the mutants was
found to be able to co-precipitate with P protein. Clearly, mutants
that can form proper oligomeric structures and retains their C-
terminal P-interacting region (320–390aa) intact, can bind P, i.e.
N(22–422) and N(1–390). This reinforces the involvement of 320–
390 aa of N in oligomer N-P interaction. On the other hand,
mutants either lacking this C-terminal region i.e. N(1–320), N(1–
220) or unable to form characteristic oligomeric structures i.e.
N(48–422), N(1/180–265/422) are also found to interact with P.
This can only be explained in light of the N-terminal P interacting
region of monomeric N. Only N(180–422) failed to interact with P,
as it neither has an intact N-terminal P interacting domain, nor
can it form proper oligomeric structures that is necessary for the
utilization of the C-terminal domain for binding P. N(1–47)
showed P interaction ability under this condition, albeit to a lesser
degree than other mutants. Taken together, this co-immunopre-
cipitation data strongly supports our in vitro His-tag co-elution
results, confirming the presence of two independent P binding
domains within N.
P inhibits oligomerization of N by partially masking its
self-association domain
From the data presented so far, it is evident that in addition to
the C-terminal P binding domain, the CHPV N possesses another
unique N-terminal P interacting region which is functional only in
the monomeric form of the protein. Now, the self-association
domain of N has been reported to reside in the chymotrypsin
resistant N-terminal 320 amino acids of the protein [21]. On the
basis of these two observations we hypothesize that P partially
Figure 6. Ex vivo expression and immunoprecipitation of different N mutants with P. (A) Intra-cellular distribution of different mutants of N
used in this study. Vero-76 cells were transfected with 2 mg of pEGFP-C1 constructs of each mutant. N-terminal deletants N(48–422) and N(180–422)
exhibits smooth distribution. N(1–47) also exhibits smooth distribution, probably because of the large GFP-tag, which interferes with its
oligomerization. The bar represents 5 mm. (B) Co-expression of wild-type N and different N mutants with P protein in Vero-76 cells. Co-expression was
confirmed by immunobloting with N and P Abs (upper and lower panels, respectively). All of the mutants used for this study expresses satisfactorily,
and is of the right relative size. (C) Co-immunoprecipitation of wild-type N and different N mutants with P protein. Vero-76 cells were co-transfected
with 2 mg of both plasmids, labelled with L-Methionine-
35S 24 hours post-transfection followed by immunoprecipitation with P Ab. Except for N(180–
422), all mutants co-immunoprecipitate with P.
doi:10.1371/journal.pone.0034623.g006
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vital for N-N self association and thereby maintains N in its
monomeric form (N
0).
To validate our hypothesis, we have chosen the mutant N(1–
320) which lacks the C-terminal P interacting region but possesses
the N-terminal one. Also, this is the largest possible C-terminal
deletion of the protein retaining the ability to form characteristic
oligomeric structures like the wild-type N [21]. Now, if our
hypothesis is true, P should be able to exhibit chaperone like
activity upon this mutant and therefore inhibit its self-association.
To evaluate this, we dissociated the oligomers of N(1–320) with
DOC and then allowed them to re-associate by dialysing out the
DOC in presence or absence of P. Similar experiment with wild-
type N resulted in formation of monomer N-P complex at the
expense of oligomers (Figure 3). Interestingly, oligomerization of
N(1–320) was also significantly inhibited in presence of P, as
evident from the gel-filtration profiles (Figure 7A, B and C). In
contrast to DOC untreated N(1–320), which eluted close to the
void volume of the S-200 column at 9.5 ml, DOC treated N(1–
320) formed a number of low molecular weight complexes with P,
majority of which eluted at 13.5 ml (Figure 7A, B and C).
Estimated molecular weight of this complex (,70 kDa) is in the
close proximity to that of a heterodimer composed of one N(1–
320)
0 and one P. However, complexes of other stoichiometry are
also observed. This certainly suggests that a major fraction of N(1–
320) is retained in its monomer form by forming a 1:1 complex
with P. DOC treatment does not have any permanent effect upon
the oligomerization ability of the protein as was evident from the
identical gel-filtration profile of the DOC removed and untreated
sample (not shown). In agreement with the His-tag co-elution data,
P fails to interact with oligomeric N(1–320) (DOC untreated) and
therefore, does not have any effect upon its gel-filtration profile .
Thus, the N-terminal 320 amino acids of CHPV N have all the
necessary contacts to interact with P under monomeric conditions.
Next, to substantiate this observation ex-vivo, we monitored the
effect of co-expression of P upon the cellular distribution of GFP-
N(1–320). As evident from Figure 7D, co-expression of P in 1:1
ratio significantly affect the aggregation tendency of N(1–320) and
resulted in a smooth distribution of this protein throughout the
cytoplasm (compare Figure 6A, N(1–320) and 7D). Co-expression
of P and its co-localization with N were verified by immunoflu-
orescence with P Ab (Figure 7E and F). Further, co-expression of
N(1–320) with P in 1:0.5 ratio did not have any such effect upon
the cellular distribution of the aggregated structure of N(1–320)
(Figure 7G), as was the case for wild-type N. However,
interestingly in this case, unlike the interaction of P with wild-
type N under similar conditions, here, P failed to co-localize with
the aggregated structures of N as evident from the immunofluo-
rescence data (compare Figure 7G, H, I with Figure 1H, I, J).
Clearly, P could not interact with the oligomers of N(1–320) due to
the absence of the C-terminal domain of N, as also evident from
the in vitro gel-filtration analysis.
Discussion
Recent work with the CHPV N protein has put an emphasis on
the obligatory role of monomer N (N
0) in specific encapsidation of
the viral genome in presence of large excess of cellular RNAs,
during viral replication [21,29]. However, maintenance of N in an
encapsidation competent monomer form is entirely dependent
upon its interaction with the P protein, i.e. the formation of a N
0-P
complex [26,28,29]. Regions of VSV or RAV P protein involved
in this interaction have been found to be situated at the extreme
N-terminal end of the protein [14,37], which is distinct from the
nucleocapsid binding C-terminal domain (PCTD) [32]. Reports
with Sendai virus also supported the presence of such N
0 binding
domain at the N-terminal region of P [35]. However, for the N
protein, a major void has remained in regard to the regions of N
0
that participate in this interaction. This is primarily due to the lack
of soluble preparations of monomeric N (N
0), which till date has
been a major hurdle to structural and biochemical study of the N
0-
P complex.
Co-expression of VSV N and P proteins in different expression
systems results in formation of multiple N-P complexes of various
stoichiometries [24]. Among them, two complexes have been
found to be functionally relevant during the viral infection cycle,
namely, a 2:1 N-P complex corresponding to the decamer-N-
RNA-P interaction, and a complex representing the interaction of
monomer N with monomers or dimers of P (N
0-P). It appears that,
within the system, these two complexes remain in equilibrium, and
probably for this reason, it is difficult to modulate the abundance
of one of these complexes at the expense of the other. Here we
have been able to reconstitute the formation of both oligomer N-P
and monomer N-P complexes in vitro, independent of one another.
Incubation of individually expressed (bacterial) soluble N and P
proteins together, resulted in a high molecular weight complex,
composed of octameric/decameric nucleocapsid like structures of
N associated with P in 2:1 ratio. This complex vastly resembles the
VSV N-P complex encountered by Green et al. while co-
expressing N-P in E. coli [18]. It is representative of the interaction
of P as a polymerase co-factor with the nucleocapsid template
[32]. It is thus noteworthy that, P binding ability is hardwired into
the nucleocapsid like structures of N and is retained even if
expressed independently. In contrast, reversible disruption of the
oligomers of N with the dissociating detergent, Sodium Deoxy-
cholate (DOC) resulted in generation of N
0 [29], which was also
found to interact with P (Figure 3) to form N
0-P complex.
Moreover, formation of this complex resulted in inhibition of N-N
self-association, re-establishing the role of P in retaining N in its
monomeric form. Interestingly, these in vitro results are in
accordance with our ex-vivo data, where dual mode of N-P
interaction is reflected when co-expressed in live cells. According
to our observations, co-transfection of N and P in a 1:1 ratio
resulted in solubilisation of aggregated N, and co-localization of
the two proteins together, indicating N
0-P complex formation.
However, co-transfection in a 1:0.5 ratio resulted in co-localization
of the otherwise homogenous P, with punctate N, which we deem
to be representative of oligomer N-P complexes. A similar
observation has been described by Omi-Furutani et al. for the
Nipah virus [42]. Therefore, it is evident that by varying the
availability of P protein we can alter the mode of N-P interaction
in live cells.
In the present work, we have successfully identified two unique
P interacting regions in the CHPV N protein. While a C-terminal
region has been found to bind P only under oligomeric conditions,
another N-terminal region has been identified, which mediates
interaction of monomeric N with P (N
0-P). Primary indications for
the possibility of these two independent domains came from His-
tag co-elution assays with different truncated versions of the N
protein, either untreated or pre-treated with 1% DOC. It has been
found that DOC untreated oligomer N possesses a C-terminal P
binding domain residing between residues 320–390. However, this
P binding domain is only active in the proper nucleocapsid like
decameric structures of N, as evident from the incapability of
mutants N(180–422) and N(1/180–265/422), to interact with P
under similar conditions. These mutants although retain their C-
terminal domain intact, lacks the ability to form proper
nucleocapsid like structures like the wild-type protein. Presence
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previously by the crystal structure analysis of VSV nucleocapsid-
RNA-P complex [32]. According to this report, in VSV N, a
contiguous stretch of residues (354–386) in the C-terminal domain
of P, including helix a-13 and the extended loop of the C lobe,
form the P interacting site. Moreover, in decamers of N, this P
binding domain from two neighbouring N monomers come
together to form a unique P binding site, thereby restricting such P
binding activity to the nucleocapsid structure only. This could be a
general strategy for both VSV and CHPV to minimize the chances
of recruitment of viral polymerase to defective nucleocapsid
structures, thereby optimizing their RNA synthesis. Also, possibil-
ities of additional residues that may play role in this interaction
could not be excluded. This is because, in the case of N(1–390), P
interaction ability is significantly affected by deletion of the
extreme C-terminal 32 amino acids. This result that can be
explained by considering the observation made by Takacs et al.
[41] which suggested the involvement of C-terminal 5 amino acids
in N-P interaction. It seems that although the actual P binding site
resides within 320–390 amino acids of N, the extreme C-terminal
region is also involved in maintaining proper conformation of the
P binding site.
On the other hand, P interacting ability of N(48–422) in the
His-tag co-elution assay, opens up the possibility of a new P
interacting region within N. This is because, N(48–422) is
incapable of oligomerization and exists solely as a monomer,
and thus, does not have a functional PCTD interacting site. This
possibility was further validated by P interaction ability of the
mutants N(1–320), N(1–220), N(1/180–265/422) in their mono-
mer forms generated by prior treatment with DOC. N(1/180–
265/422) is interesting in this respect because, though it does not
form decameric structures, it is capable of forming dimers
(Table 1), which, as evident from the data presented here is not
adequate to bind to P. Therefore, this N-terminal P binding
domain is only functional in the monomeric form of the protein.
The ability of N(1/180–265/422) to interact with P upon DOC
treatment reduced this binding domain to the first 180 residues of
the N protein. However, the decreased binding of N(1–220) as
compared to N(1–320) and N(1/180–265/422) under DOC
treated conditions, also indicates the possible role of residues 265
to 320 in this interaction. This His-tag co-elution data was further
supported by co-immunoprecipitation assays where all of the
mutants, except N(180–422), co-precipitated with P, when the two
proteins were co-expressed in Vero-76 cells. Therefore, it is again
evident that the first 179 amino acids of monomer N are
indispensible in binding P. Interestingly, N(1–47) which failed to
interact with P in DOC treated or untreated forms in the His-tag
co-elution assay, co-precipitated with P when co-expressed. In this
context, it is noteworthy that this short peptide has high
oligomerization tendency when expressed in E. coli but loses the
same upon expression as a GFP-fusion protein. Probably the GFP
fusion affects the structure of this short peptide and is responsible
for its anomalous behaviour.
A challenging question that remains is how interaction with P
inhibits the self-association of N and therefore, maintains it in its
soluble form. We have previously shown that formation of helical
nucleocapsid like structure of CHPV N is dependent upon the
interaction of the N-terminal arm (residues 1–47) of one N
monomer with the central region (residues 180–265) of another
adjacent N moiety [21]. Any interference in these sites of
Figure 7. Monomers of N(1–320) binds to P, but oligomers do not. Size exclusion chromatography of bacterially expressed purified N(1–320)
and P proteins, visualised by Coomasie brilliant blue staining. (A) N(1–320) alone. (B) N(1–320) treated with 1% DOC (to dissociate the oligomers into
monomers) for 30 minutes and subsequently dialysed to remove DOC in the presence of equimolar concentrations of P protein. Co-elution of the
two proteins confirms that N(1–320) can bind to P in monomeric state. (C) Plot representing densitometric scans of N(1–320) bands with respect to
elution volume in ml. (D) GFP fluorescence of Vero-76 cells co-transfected with 1:1 ratio of pEGFP-C1 N(1–320) and pCDNA 3.1 (+) P. Smooth
distribution of N(1–320) is observed. (E) Immunofluorescence of the cells in D with P Ab. P also shows smooth distribution. (F) Merge of D and E. (G)
GFP fluorescence of Vero-76 cells co-transfected with 1:0.5 ratio of pEGFP-C1 N(1–320) and pCDNA 3.1 (+) P. N(1–320) shows punctuated distribution.
(H) Immunofluorescence of the cells in G with P Ab. Distribution of P is smooth. (I) Merge of G and H. All data were captured on a laser scanning
confocal microscope (Carl Zeiss). P Immunofluorescence were performed with anti-rabbit TRITC conjugated secondary antibody. 2 mg of DNA was
used for all transfection, except for G, H and I where 1 mg of pCDNA 3.1 (+) P was used. The bar represents 5 mm.
doi:10.1371/journal.pone.0034623.g007
Interaction of CHPV N and P Proteins
PLoS ONE | www.plosone.org 10 April 2012 | Volume 7 | Issue 4 | e34623interaction should either result in total abrogation of oligomer
formation or in defective self-association. Interestingly, our data
indicates that the N-terminal P interacting region of N partially
coincides with its oligomerization domain. We therefore propose
that association of P to this N-terminal binding site of nascent N
either partially or completely masks the self association domains of
N, resulting in maintenance of N in its monomeric form (N
0).
Support in favour of this mechanism came when DOC treated
N(1–320) was allowed to form oligomers in presence of the P
protein. It must be remembered that N(1–320) is the smallest
possible C-terminal truncation of the N protein retaining its ability
to form characteristic oligomeric structures like the wild-type
protein [21]. Gel-filtration analysis clearly indicates that presence
of P severely affects the self-association tendency of DOC treated
monomer N(1–320), which co-elutes as a slower migrating N(1–
320)
0-P complex. Furthermore, co-expression of N(1–320) with P
in live cells in 1:1 ratio resulted in redistribution of the punctate
structures of this protein into a homogeneous form, confirming the
chaperone like activity of P upon N(1–320). Together, these data
confirms that interaction of P with the N-terminal portion of N is
sufficient to block the N-N self-association and subsequently
inhibit the oligomerization process. Our data validates the
prediction made by Curran et al. [35] where it had been proposed
that interaction of P at the self-association domain of monomer N
prevents N
0-P from aggregation. However, in a pre-formed
nucleocapsid this domain is involved in interaction with
neighbouring N subunits and hence unavailable for interaction
with P. In such form, the C-terminal domain represents the only
binding site for P. A similar observation has been reported recently
by Leyrat et al., where they have shown that the N
0-binding region
of P competes with the N terminal arm of a neighbouring N
molecule, thus preventing N-N self assembly [33,43].
Finally, we present a model (Figure 8) that explains the specific
encapsidation of viral RNA during viral genome replication.
Nascent N is maintained in an encapsidation competent soluble
form (N
0) by its interaction with the P protein (by N
0-P complex
formation). In this context, P masks the self-association domain of
N and thus maintains it in a monomer form. Previously, we have
shown that CHPV N
0 is capable of specifically recognizing the
viral leader sequence and the C-terminal 102 amino acids are
essential for this recognition. On the other hand, upon
oligomerization, a new RNA binding cavity is formed utilizing
the N-terminal arm (1–47 aa) and the central region of N [21].
Therefore, the P bound monomeric N specifically recognizes the
leader region of the viral genome RNA, to form the nucleation
complex. This may be a transient state, immediate to which, the
process of N-N self-association begins. For this purpose, the P has
to be released by a yet unknown mechanism. The polymerase L
may have a role in this process. Studies with VSV indicated that P
shares an overlapping N-terminal region for interaction with L
[44] and with N
0 [14]. Hence, interaction with L, within the close
proximity of the N
0 binding site could be a thrust to replace the N
from P. Release of P from N
0 unmask its self-association domain,
hence can trigger the N-N self-association to begin, leading to
helical nucleocapsids. During this self-association, a new RNA
binding surface is generated using the N-terminal two-third of N,
which is capable of accommodating diverse RNA sequences in the
elongation phase of encapsidation [21]. In this context, it is worth
mentioning that the N-terminal non-specific RNA binding domain
is only available in self-associated N [21]. Once nucleocapsids
have formed, P can again interact with N, this time with the C-
terminal region of oligomeric N, to usher the viral polymerase (L)
onto its template.
It is interesting to note that CHPV nucleocapsid not only shares
common architecture with other viruses in the Rhabdoviridae family
[21] but also employs common strategy for encapsidation of its
genome RNA. This also point towards the possibility of existence
of similar N-terminal P binding regions in the N proteins of other
Mononegalovirales as well. This newly elucidated P binding region
may serve as a potential target for designing novel therapeutics
interventions.
Materials and Methods
Oligonucleotides used in this study were purchased from
Integrated DNA Technologies (IDT), USA. All column chroma-
tography materials were from GE Healthcare. Ni-NTA resin was
from Qiagen. Foetal Bovine Serum, antibiotics and Trypsin-
EDTA needed for cell culture purpose were supplied by
Invitrogen
TM (GIBCO). Radioactive biomolecules were from
BRIT, India. All other chemicals and biochemicals were of
analytical grade.
Cell lines
Vero-76 cell lines supplied by NCCS, Pune were grown as
monolayers in DMEM enriched with 10% FBS, 100 U/ml
Penicillin-Streptomycin, 2 mM Glutamine in tissue culture treated
Figure 8. Schematic representation of the domains of CHPV N
involved in interaction with P and their functional importance.
Binding of P to nascent N masks the N-N self association region of CHPV
N( N
0-P complex formation) and also blocks non-specific RNA binding
(upper panel). N
0 is capable of specifically recognizing the viral leader
sequence and the C-terminal 102 amino acids are essential for this
recognition. Therefore, in the monomeric form, N specifically recognizes
the leader RNA, to form the nucleation complex. Subsequently, the
process of N-N self-association begins and P is released. Upon
oligomerization, a new RNA binding cavity is formed utilizing the N-
terminal arm (1–47 aa) and the central region of N (lower panel). Thus,
the phase of non-specific encapsidation begins. Once nucleocapsids
have formed, P can again interact with N, this time with the C-terminal
region of oligomeric N, to usher the viral polymerase (L) onto its
template.
doi:10.1371/journal.pone.0034623.g008
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humidity and 37uC temperature.
Construction of plasmids and expression of the wild-type
and deletant proteins
Different GFP tagged, truncated versions of CHPV N were
created by PCR amplification from pET3a-NC [21] and
subcloning into pEGFP-C1 vector by using BamHI and KpnI
restriction enzymes (Fermantas, Thermo scientific) (see Table 2 for
primers used in this process). GFP tagged N(1/180–265/422) was
obtained by a similar strategy using previously available pET3a-
N(1/180–265/422) as the template [21]. N(48–422) and N(180–
422) for bacterial expression was created by subcloning into
pET3a using pET3a-NC as template. All clones were confirmed
by sequencing.
All full-length and deletion mutants of N were expressed in E.
coli, BL21(DE3) or in BL21(DE3) pLysS. The expression and
purification of full-length untagged protein was carried out as
described earlier [21,27]. Wild-type P (pET3a-P) and 66His
tagged P (pET20b-P) were purified by Q-Sepharose anion
exchange resin (GE Healthcare) as described previously by
Chattopadhyay et al. [45] or Ni-NTA agarose (Qiagen) according
to manufacturers protocol. Eukaryotic expression of wild-type
GFP-N (pEGFP-C1 N), Wild-type untagged P (pCDNA 3.1(+) P),
has been described previously [16].
Gene Transfection
One day prior to performing transient transfection, 35 mm
tissue culture plates (containing coverslips for immunofluores-
cence) were seeded with 4610
5 Vero-76 cells per well. Cells were
transiently transfected with 2 mg of either pEGFP-C1 containing
cDNA of wild-type or mutant forms of CHPV N alone, or co-
transfected with 2 mg (or 1 mg) pCDNA 3.1(+) containing cDNA of
CHPV P. Transfection were performed with 6 ml of TurboFect
TM
in vitro Transfection Reagent (Fermentas) according to manufac-
turer’s protocol.
Immunofluorescence
Polyclonal anti-CHPV N and anti-CHPV P has been described
previously [21,46]. Immunofluorescence of cultured cell was
performed according to standard protocol. Briefly, 24 hours
post-transfection, cells were washed with ice cold phosphate buffer
saline (PBS) twice, and fixed with 2% para-formaldehyde (PFA) at
room temperature for 40 minutes. After thrice washes with PBS,
cells were permeabilized with 10 mM Na-citrate, pH-6.0 contain-
ing 0.1% Triton X 100 at room temperature for 20 minutes and
blocked with 5% bovine serum albumin in PBS (Invitrogen, USA)
for 1 hour. Primary antibody (1:200) was treated at 4uC,
overnight. Anti rabbit secondary TRITC conjugated antibody
was added (1:300) after three PBS washes. After incubation for
1 hour, cells were washed three times with PBS. Finally, the
coverslips were mounted with anti-fade mounting media and
evaluated using the 663 objective of a confocal microscope (Carl
Zeiss) equipped for GFP visualization (488-nm excitation and
FITC filter set) and TRITC visualization (543-nm excitation and
TRITC filter set). The images were corrected for possible cross-
talk by sequential scanning in multiple channels using the multi-
track configuration.
Soluble-insoluble fractionation and sucrose density
gradient centrifugation
At 24 hrs of post-transfection, cells were washed with phosphate
buffer saline (PBS) and lysed in lysis buffer (20 mM Tris-HCl
(pH 8), 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1%
TritonX-100, 5 mM DTT) and sonicated on ice with a 5 second
pulse. After centrifugation at 13000 rpm at 4uC for 30 minutes,
the supernatant containing the soluble protein pool were layered
over a 10–60% sucrose step gradient and were centrifuged for
16 hours at 32000 rpm in a SW44 Beckman rotor at 4uC. 0.5 ml
fractions were collected from the bottom of the gradients,
precipitated with Trichloroacetic acid (TCA) and resolved in a
12% sodium dodecyl sulphate-polyacrylamide gel electrophoresis
(SDS-PAGE). Gels were Western blotted (WB) with N and P
antibodies to check their distribution pattern, according to
standard protocols. Densitometric analysis of WB were performed
with ImageQuant
TM TL software (GE Healthcare) within the
linear dynamic range of detection.
In vitro N-P interaction
Equimolar amounts of bacterially expressed, purified N and P
proteins were incubated together in 100 mM NaCl containing
TET buffer (50 mM Tris pH 8.0, 1 mM EDTA and 0.1% Triton
X-100), at 4uC for 30 minutes. The resulting complex was then
subjected to gel-filtration chromatography through S-200 (10/300)
column (GE Healthcare), pre-equilibrated in the same buffer. For
dissociation of the N oligomers, N was pre-treated with 1%
Sodium Deoxycholate (DOC) at room temperature for 30 minutes
followed by overnight dialysis against 100 mM NaCl containing
TET buffer in presence of equimolar amounts of P protein. The
resulting adduct were then subjected to gel-filtration chromatog-
raphy as mentioned above. 0.5 ml fractions were collected, and
resolved on 12% SDS-PAGE. Bands were visualised by silver
staining and densitometric analysis of bands were performed with
Table 2. Oligonucleotides used for the construction of the GFP fused truncated N proteins.
Construct Forward Primer (KpnI) Reverse Primer (BamHI)
pEGFP-C1 N(22–422) CGGGGTACCGACCCAGTGGAGTTTCCA TTTATAGGATCCTCATGCAAAGAG
pEGFP-C1 N(48–422) CGGGGTACCGATCTGAGTCTTTTGAGGAG TTTATAGGATCCTCATGCAAAGAG
pEGFP-C1 N(180–422) CGGGGTACCGAATTCTTCAATGCTTGGGC TTTATAGGATCCTCATGCAAAGAG
pEGFP-C1 N(1–47) CGGGGTACCATGGCCAGTTCTCAAGTATTCTGCATTT CGCGGATCCTCATGTCTCCTTCTTTATGTACAC
pEGFP-C1 N(1–220) CGGGGTACCATGGCCAGTTCTCAAGTATTCTGCATTT CGCGGATCCTCACACAATTGTTCCGAAACG
pEGFP-C1 N(1–320) CGGGGTACCATGGCCAGTTCTCAAGTATTCTGCATTT TTTATAGGATCCTCATGGAACTAAAGCATTCTT
pEGFP-C1 N(1–390) CGGGGTACCATGGCCAGTTCTCAAGTATTCTGCATTT TTTATAGGATCCTCAAATTTCATGCTTAATATCCT
pEGFP-C1 N(1/180–265/422) CGGGGTACCATGGCCAGTTCTCAAGTATTCTGCATTT TTTATAGGATCCTCATGCAAAGAG
doi:10.1371/journal.pone.0034623.t002
Interaction of CHPV N and P Proteins
PLoS ONE | www.plosone.org 12 April 2012 | Volume 7 | Issue 4 | e34623ImageQuant
TM TL software (GE Healthcare) within the linear
dynamic range of detection.
His-tag co-elution assay
Wild-type or truncated N proteins were incubated with 66His-
P protein in binding buffer (50 mM Tris-Cl, pH-8, 100 mM NaCl,
0.1% TritonX-100 and 10 mM Imidazole), at 4uC for 30 minutes
and the resulting complexes were allowed to bind to Ni–NTA
agarose pre-equilibrated in the same buffer. A 10 ml aliquot of the
complex was kept aside before addition of Ni-NTA, as loading
sample (L). Binding was allowed for 1 hour, and the flow-though
(FT) was collected. After consecutive washings with 10 mM (W),
20 mM and 50 mM Imidazole, the proteins were finally eluted
with 250 mM Imidazole (E). L, FT, W and E were resolved in
12% SDS-PAGE and visualised by Coomassie Blue Staining.
Alternatively, N variants were treated with 1% DOC and dialysed
against the binding buffer in presence of P protein. The complexes
formed were subjected to the co-elution assay mentioned above.
Co-immunoprecipitation
pCDNA 3.1-N and pCDNA 3.1-P were co-transfected into
Vero-76 cells, grown in 35 mm culture plates. At 24 hours of post-
transfection, cells were starved in DMEM lacking methionine and
cysteine (PAN Biotech) for another 30 min and then exposed to
50 mCi/ml of
35S labelled methionine and cysteine (
35S INVIVO
ProTwinlabel; BRIT, India) in the same medium, for 2 hrs. Cells
were then washed with PBS and lysed as mentioned previously.
Lysates were incubated overnight with polyclonal anti-P antibody
(1:400 dilution) and the protein complexes were immunoprecip-
itated using Protein-A Sepharose
TM CL-4B (GE Healthcare) for
one hour, according to manufacturer’s instructions. After
subsequent washing with lysis buffer, the sepharose beads were
boiled with 16 protein loading dye for 5 minutes and samples
were resolved in a 10% SDS-PAGE and subjected to autoradi-
ography.
Supporting Information
Figure S1 CHPV P proteins acts as an N-specific
chaperone when transfected at a 1:1 ratio in Vero-76
cell lines. Upon transfection of Vero-76 cells with GFP-N and P
encoding constructs in a 1:1 ratio, about 90% cells exhibited
homogenization of the otherwise punctated distribution of GFP-N.
The remaining 10% cells, were found to be lacking in the
expression of P, and therefore showed characteristic punctated
structures of N. This image shows the three possible types of cells
in one field. Cells co-transfected with both GFP-N and P plasmids
resulted in homogenization of N aggregates (NGFP+P). Cells that
were transfected with GFP-N alone continued to exhibit punctated
pattern of GFP-N distribution (NGFP), while cells that received P
alone, showed typical homogenous distribution of P throughout
the cytoplasm (P-IF). Immunofluorescence against P was per-
formed with P Ab and anti-rabbit TRITC conjugated secondary
antibody. Images were captured on a laser scanning confocal
microscope (Carl Zeiss). The bar represents 5 mm.
(DOC)
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